ANEB
NASDAQ · Pharmaceuticals
Anebulo Pharmaceuticals Inc
$0.26
+0.00 (+0.00%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+19,126.9% upside
Low Target
$34.23
Average Target
$49.99
High Target
$60.95
Current Price
$0.26
Current
$0.26
$0.26
Target
$49.99
$49.99
$34.23
$49.99 avg
$60.95
Scenario Analysis
Bear Case
$34.23
13,065.4%
Low target
Base Case
$49.99
+19,126.9%
Avg target
Bull Case
$60.95
+23,342.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
Target vs 52W High
$49.99
+1,786.4% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $-0.11
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals